9

Overview of the Potency of Moxifloxacin Ophthalmic Solution 0.5% (VIGAMOX®)

Year:
2005
Language:
english
File:
PDF, 142 KB
english, 2005
10

Author's Response

Year:
2006
Language:
english
File:
PDF, 65 KB
english, 2006
19

BB-K 122: in vitro and in vivo activity against ocular pathogens

Year:
1981
Language:
english
File:
PDF, 563 KB
english, 1981
22

Clinical and Epidemiological Advantages of Culturing Bacterial Keratitis

Year:
2004
Language:
english
File:
PDF, 258 KB
english, 2004
24

Evaluation of BL-P1654

Year:
1984
File:
PDF, 360 KB
1984